Show results for
Refine by
Disease Progression Suppliers Serving Usa Idaho
97 companies found
based inCambridge, MASSACHUSETTS (USA)
Founded in 2018 by a team of accomplished scientists with a proven track record in drug discovery and executive leadership in top global biopharmaceutical companies, Regor is a pioneering international biotech company with headquarters in Shanghai, ...
based inGwangmyeong-si, SOUTH KOREA
Hue Light Co., Ltd specializes in advanced wellness devices with a focus on photobiomodulation (PBM) and hydrogen therapies. Their PBM treatment devices aim to utilize light wavelengths to potentially assist in cellular repair, inflammation ...
The HBOT-130 Medical Hyperbaric Oxygen Chamber by Hue Light Co., Ltd is designed for hospital-grade therapeutic applications, specifically to enhance oxygen delivery in clinical settings. Utilizing medical-grade 304 stainless steel, this chamber ...
based inToronto, ONTARIO (CANADA)
20+ Years of Innovation! FUJIFILM VisualSonics designs and manufactures ultra high frequency in vivo imaging systems, for both research and clinical use. FUJIFILM VisualSonics specifically focuses on developing ultrasound technology that has been ...
based inFremont, CALIFORNIA (USA)
Moximed, Inc. is dedicated to improving the standard of care for patients with osteoarthritis (OA). OA, the most common form of arthritis, leads to a breakdown of the joint’s cartilage and often results in joint pain and loss of motion. Moximed was ...
In knee OA, the joint surface begins to break down. This joint surface is normally covered with cartilage, the firm material at the bone ends that acts as a cushion against shocks. As the cartilage of an OA sufferer’s joint wears away, the ...
based inNew York, NEW YORK (USA)
Oramed Pharmaceuticals (NASDAQ: ORMP) has developed an innovative technology to transform injectable treatments into oral therapies. Oramed’s flagship product, an oral insulin capsule, has the potential to better the lives of millions of diabetics ...
Diabetes is a chronic condition characterized by hyperglycemia, or elevated blood glucose levels. If left untreated, diabetes may lead to complications such as cardiovascular disease, chronic renal failure, retinopathy and ...
based inWest Lafayette, INDIANA (USA)
Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...
based inHouston, TEXAS (USA)
We are a CLIA high complexity laboratory and a developer and manufacturer of blood diagnostic tests. We specialize in molecular testing and Point of Care immunoassay. At Accel Diagnostics our mission is to transform the way a wide variety of medical ...
A Rapid Test for the Quantitation of the Titer of Antibody Against the Spike Protein of the SARS-COV-2 VIRUS. Accel Diagnostics’ rapid quantitative COVID-19 serology assay for the detection and qualification anti-Spike SARS-COV-2 antibody ...
based inEden Prairie, MINNESOTA (USA)
ProUroCare is engaged in the business of developing innovative products for the detection and characterization of prostate disease. Our initial product is a “prostate mechanical imaging” device called the ProUroScan System. The ProUroScan is an ...
Our second product, the ProUroVision system, is a proprietary vision technology for thermal therapy systems designed to aid in the treatment of BPH and other prostate diseases. Thermal therapy is a minimally invasive catheter-based therapy that uses ...
based inRiverside, CALIFORNIA (USA)
Therapeutics has looked at Alzheimer's disease with new eyes. We have assembled an amazing team of dedicated professionals who are focused on curing Alzheimer’s disease. This mission-oriented team discovered a major trigger for Alzheimer’s disease ...
based inBedminster, NEW JERSEY (USA)
Jubilant Therapeutics Inc. is a clinical stage precision therapeutics company advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. With an advanced discovery engine which ...
Strong scientific and clinical rationale for PAD4 inhibitors in autoimmune ...
based inVirum, DENMARK
Immudex was created in 2009 when it spun off from the diagnostic company Dako, now Agilent. Since then, Immudex has grown in numbers, employees, patents, product lines, partnerships, and customers served. Research, development, and commercial ...
based inWaltham, MASSACHUSETTS (USA)
PrismRA is a molecular signature response classifier (MSRC) that uses gene expression features, clinical features and anti-cyclic citrullinated protein (anti-CCP) antibody to detect a signature of non-response to tumor necrosis factor-a inhibitors ...
PrismRA is a personalized blood test ordered by your rheumatologist that delivers insights into which RA medication will work best based on your biology. ...
based inParis, FRANCE
Qynapse, through QyScore, brings groundbreaking peace of mind to the global fight against CNS disease. Qyscore is a medical device software FDA-cleared – class II and CE-marked – class IIa (CE BSI). Qyscore is a medical device software FDA-cleared ...
The software is intended to be used by medical personnel or neuroimaging trained personnel to support diagnosis of central nervous system diseases. Available for research use only and protected by 3 patents, QyPredict has the ...
based inRochester, MINNESOTA (USA)
Resoundant, Inc. is a medical technology company founded by Mayo Foundation for Medical Education and Research and is located in Rochester, MN. Resoundant is dedicated to improving patient care and diagnosis accuracy by making Magnetic Resonance ...
Resoundant offers Core Lab services in collaboration with the Mayo Clinic scientists and medical professionals who invented MR Elastography over 20 years ago. Today, Resoundant and Mayo Clinic continue to support the ongoing advancement of MRE ...
based inSan Francisco, CALIFORNIA (USA)
We were founded with the mission of creating a world without infectious disease. We are a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. ...
based inCarlton South, AUSTRALIA
Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. We believe that cellular therapies have the promise to cure cancer not just delay disease ...
based inOakland, CALIFORNIA (USA)
Eko is your all-in-one screening and telemedicine solution, helping you detect cardiac conditions easier and provide timely care from anywhere. The ability to listen is the ability to care. Eko understands how important listening can be for ...
DUO is the first cardiac assessment tool that functions as an ECG and digital stethoscope, used to detect early signs of heart disease and facilitate more personalized care in any environment. DUO can be used with or without included ...
based inKiel, GERMANY
tiakis biotech AG (“tiakis”) – formerly Proteo Biotech AG - is the next generation preventive therapeutic technology company. We focus on our clinical-stage proprietary and pioneering tissue protective drug ...
Tiprelestat is a pioneering anti-inflammatory and tissue protective drug being developed for the treatment of pulmonary-arterial hypertension, the prevention of serious disease progression of COVID-19 and the ...
based inTirat Carmel, ISRAEL
Our mission is to translate the complex signals of the immune system into simple diagnostic insights that transform the way we treat infectious diseases and inflammatory disorders – at the right place and the right time. MeMed’s interdisciplinary ...
Some infections resolve quickly, while others lead to severe immune dysregulation, respiratory failure and death. Distinguishing between the two is challenging.MeMed COVID-19 Severity builds on an extensive body of evidence supporting the role of ...
based inBundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
AdAlta is utilising the power of the i-body technology platform to develop a growing pipeline of i-bodies to treat a range of conditions, with an initial focus on treating fibrotic diseases. AdAlta identified an i-body that binds to the drug target, ...
